Jonathan Davis BA, PhD

Jonathan Davis received his Ph.D. from University of California, San Francisco, where he worked on protein structure and function. After a post-doc at Harvard Medical School studying RNA selection, structure, and function in the labs of Jack Szostak and Gerhard Wagner, he took a position in the New Technologies at EMD-Lexigen (now EMD Serono) in Billerica, MA. His work there involved improving antibody-based therapeutics, inventing a platform technology for generating heterodimeric Fcs as a basis for multifunctional molecules, and developing a novel scaffold based on an artificially-designed protein.

He has extensive experience in selection technologies, library design, in silico modeling, and therapeutic discovery. In 2008 he moved to Adnexus, now Bristol-Myers Squibb, located in Waltham, MA, where he is a Principal Scientists in Molecular Structure and Design, working on projects ranging from improving optimization protocols to development of novel biotherapeutics.